Title: First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy
Authors: d'Amore, Francesco
Leppa, Sirpa
da Silva, Maria Comes
Relander, Thomas
Brown, Peter De Nully
Weidmann, Eckhart
Lauritzsen, Grete Fossum
Pezzutto, Antonio
Van Hoof, Achiel
van Gelder, Michel
Doorduijn, Jeanette K
Wu, Ka Lung
Kluin-Nelemans, J. C
Lugtenburg, P. J
Jankovska, Milada
Merup, Mats
Fagerli, Unn-Merete
Walewski, Jan
Hagberg, Hans
Mariz, Jose Mario
Hansen, Per Boye
Noesslinger, Thomas
Janssens, Ann
Brandefors, Lena
Demuynck, Hilde
Schaafsma, Martyn Ronald
Christiansen, Ilse
Salek, David
Jyrkkio, Sirkku
Prochazka, Vit
Zijlstra, Josee
Bohmer, L
Greil, Richard
Stevens, Wendy
Fijnheer, Rob
Kooy, Marinus van Marwijk
Grube, Matthias
Hopfinger, Georg
Van den Neste, Eric
Jantunen, Esa
Truemper, Lorenz
Wulf, Gerald
Altmann, Bettina
Ziepert, Marita
Loeffler, Markus
Toldbod, Helle #
Issue Date: 2012
Host Document: BLOOD vol:120 issue:21
Conference: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) location:Atlanta: GA date:DEC 08-11, 2012
ISSN: 0006-4971
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Organ Systems (+)
# (joint) last author

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.